A record of what Morgan Stanley Analysis said publicly, with the source. Not advice.
Pending — not yet graded
“Notes that PB Fintech's health business NPV could decline 60-70% under the proposed IRDAI framework, while life insurance NPV is expected to remain broadly stable. The company is evaluating new products and seeking MGA regulation, but the brokerage flags risk to the top line of PB Partners' POSP business.”
Morgan Stanley Analysis’s track record (trackable calls only): 81 graded calls · 95% CI 31–52%
PB FintechBearishCalled 25 Sep 2026
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Morgan Stanley Analysis’s full track record